SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-001886
Filing Date
2008-03-20
Accepted
2008-03-20 11:46:00
Documents
2
Period of Report
2008-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b69301ape8vk.htm 8-K 14385
2 EX-10.1 THIRD AMENDED RESTATED CONVERTIBLE PROMISSORY NOTE b69301apexv10w1.htm EX-10.1 186434
  Complete submission text file 0000950135-08-001886.txt   202772
Mailing Address 85 MAIN STREET HOPKINTON MA 01748
Business Address 85 MAIN STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-06533 | Film No.: 08701295
SIC: 2834 Pharmaceutical Preparations